Zacks Investment Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.6M | Buy |
17,818
+37
| +0.2% | +$9.55K | 0.04% | 223 |
|
|
2025
Q1 | $3.98M | Buy |
17,781
+438
| +3% | +$98K | 0.04% | 243 |
|
|
2024
Q4 | $3.97M | Buy |
17,343
+313
| +2% | +$71.6K | 0.04% | 246 |
|
|
2024
Q3 | $4.16M | Sell |
17,030
-688
| -4% | -$168K | 0.04% | 240 |
|
|
2024
Q2 | $3.39M | Buy |
17,718
+1,083
| +7% | +$207K | 0.04% | 221 |
|
|
2024
Q1 | $3.29M | Buy |
16,635
+2,943
| +21% | +$583K | 0.04% | 254 |
|
|
2023
Q4 | $2.36M | Sell |
13,692
-2,308
| -14% | -$397K | 0.03% | 268 |
|
|
2023
Q3 | $2.37M | Sell |
16,000
-787
| -5% | -$116K | 0.03% | 252 |
|
|
2023
Q2 | $3.67M | Buy |
+16,787
| New | +$3.67M | 0.05% | 208 |
|
|
2022
Q2 | – | Sell |
-10,396
| Closed | -$2.52M | – | 636 |
|
|
2022
Q1 | $2.52M | Buy |
10,396
+530
| +5% | +$129K | 0.04% | 256 |
|
|
2021
Q4 | $2.57M | Buy |
9,866
+66
| +0.7% | +$17.2K | 0.04% | 268 |
|
|
2021
Q3 | $2.58M | Buy |
9,800
+581
| +6% | +$153K | 0.04% | 257 |
|
|
2021
Q2 | $2.27M | Buy |
9,219
+561
| +6% | +$138K | 0.04% | 276 |
|
|
2021
Q1 | $1.68M | Sell |
8,658
-8,383
| -49% | -$1.63M | 0.03% | 308 |
|
|
2020
Q4 | $3.62M | Buy |
17,041
+10,123
| +146% | +$2.15M | 0.07% | 189 |
|
|
2020
Q3 | $1.19M | Buy |
6,918
+2,147
| +45% | +$368K | 0.02% | 295 |
|
|
2020
Q2 | $916K | Buy |
+4,771
| New | +$916K | 0.02% | 311 |
|
|
2014
Q1 | – | Sell |
-5,427
| Closed | -$255K | – | 762 |
|
|
2013
Q4 | $255K | Buy |
5,427
+644
| +13% | +$30.3K | 0.01% | 599 |
|
|
2013
Q3 | $253K | Buy |
+4,783
| New | +$253K | 0.01% | 567 |
|